Company: AMWL
Filing Date: 2025-02-12
Form Type: 10-K
Source: 0000950170-25-019024
Chunk: 217

Company: American Well Corp
Filing Date: 2025-02-12
Form: 10-K
Item: Item 1B
Chunk 217
---

        )

        50.44

        Unvested as of December 31, 2024

        1,354,040

        $
        30.01

      The total grant date fair value of RSU’s granted for the years ended December 31, 2024, 2023 and 2022 was $37,010, $39,419 and $63,987, respectively. The aggregate intrinsic value of restricted stock units vested for the years ended December 31, 2024, 2023 and 2022 was $13,744, $18,773 and $22,218, respectively. Restricted Stock Units with a Market ConditionThe total grant-date fair value of performance-based market condition share awards granted during the year ended December 31, 2023 and 2022 was $5,805 and $63,157, respectively. No performance-based market condition share awards were granted during the year ended December 31, 2024. In the year ended December 31, 2024, the Company cancelled 422,319 restricted stock units with a market condition that were not expected to vest. The Company subsequently issued 595,462 restricted stock units to the individuals who had held the canceled awards. The cancelation and subsequent issuance was treated as a modification. 

        Shares

        Weighted AverageGrant DateFair Value

        Unvested as of January 1, 2024

        1,335,803

        $
        45.82

        Granted

        —

        —

        Vested

        —

        —

        Cancelled/Forfeited

        (559,923
        )

        54.56

        Unvested as of December 31, 2024

        775,880

        $
        39.51

      The weighted average estimated fair value of the performance-based market condition share awards granted during the year ended December 31, 2024 and December 31, 2023 was determined using a Monte-Carlo valuation simulation, with the following most significant weighted-average assumptions: 

        Years Ended December 31,

        2024
         
        2023

        2022

        Risk-free rate
         
        N/A

        4.61
        %

        2.34
        %

        Term to end of performance period (yrs)
         
        N/A
         
        3 years